Back

The discovery of PCSK9

30 August 2026 (17:30 - 17:42)
Organised by: Logo
Congress Presentation Part of: Present and the future of PCSK9 inhibition in cardiovascular prevention: from antibodies to gene editing Risk Factors and Prevention ESC Professional Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Professor Catherine Boileau

Bichat Hospital, University Paris-Diderot, INSERM-UMR1148, FACT French Alliance for Cardiovascular T, Paris (France)

4 More presentations in this session

Presentation thumbnail
The present: antibodies siRNAs
Professor K. Ray (London, GB)
Slides Video
Presentation thumbnail
Oral PCSK9 inhibitors
Doctor C. Ballantyne (Houston, US)
Slides Video
Presentation thumbnail
The future: gene editing
Professor A. Zeiher (Frankfurt, DE)
Slides Video
Presentation thumbnail
Present and the future of PCSK9 inhibition in cardiovascular prevention: from antibodies to gene editing - discussion
Video

Access the full session

Session thumbnail
Present and the future of PCSK9 inhibition in cardiovascular prevention: from antibodies to gene editing
Video

The Event

Event poster

ESC Congress 2026

30 August 2026 17:30 CET
You may be interested in
thumbnail
Congress Presentation
Pathogenesis, diagnosis and treatment of cardiovascular disease: genetic insights
31 August 2025
thumbnail
Congress Presentation
Oral PCSK9 inhibitors as an emerging frontier in lipid management: a meta-analysis
29 August 2025
thumbnail
Congress Presentation
Introduction and overview
28 August 2026
thumbnail
Congress Presentation
AAV8-mediated gene therapy for homozygous familial hypercholesterolemia
28 August 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources